PL1667655T3 - Nowe zastosowanie, preparaty farmaceutyczne oraz sposób ich wytwarzania - Google Patents

Nowe zastosowanie, preparaty farmaceutyczne oraz sposób ich wytwarzania

Info

Publication number
PL1667655T3
PL1667655T3 PL04789095T PL04789095T PL1667655T3 PL 1667655 T3 PL1667655 T3 PL 1667655T3 PL 04789095 T PL04789095 T PL 04789095T PL 04789095 T PL04789095 T PL 04789095T PL 1667655 T3 PL1667655 T3 PL 1667655T3
Authority
PL
Poland
Prior art keywords
production
well
concentrated
pharmaceutical preparations
new use
Prior art date
Application number
PL04789095T
Other languages
English (en)
Inventor
Berthold Roessler
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Publication of PL1667655T3 publication Critical patent/PL1667655T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL04789095T 2003-10-01 2004-09-28 Nowe zastosowanie, preparaty farmaceutyczne oraz sposób ich wytwarzania PL1667655T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50775003P 2003-10-01 2003-10-01
EP04789095A EP1667655B1 (en) 2003-10-01 2004-09-28 New use, pharmaceutical preparations as well as a process for their production
PCT/US2004/031650 WO2005032515A1 (en) 2003-10-01 2004-09-28 New use, pharmaceutical preparations as well as a process for their production

Publications (1)

Publication Number Publication Date
PL1667655T3 true PL1667655T3 (pl) 2012-05-31

Family

ID=34421657

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04789095T PL1667655T3 (pl) 2003-10-01 2004-09-28 Nowe zastosowanie, preparaty farmaceutyczne oraz sposób ich wytwarzania

Country Status (12)

Country Link
US (1) US8093230B2 (pl)
EP (1) EP1667655B1 (pl)
JP (2) JP4886517B2 (pl)
AT (1) ATE516014T1 (pl)
CA (1) CA2540537A1 (pl)
CY (1) CY1111960T1 (pl)
DK (1) DK1667655T3 (pl)
ES (1) ES2369776T3 (pl)
PL (1) PL1667655T3 (pl)
PT (1) PT1667655E (pl)
SI (1) SI1667655T1 (pl)
WO (1) WO2005032515A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1958618A1 (de) 2007-02-15 2008-08-20 Octapharma AG Verfahren zur Gefriertrocknung mit optimierter Rekonstitution von Biopolymeren
EP2994062B1 (en) * 2013-05-07 2019-10-02 AuXin Surgery SA Device for chemically assisted dissection
PL3092009T3 (pl) * 2014-01-06 2020-03-31 Auxin Surgery Sa Liofilozowane kompozycje mesny
BE1024110B1 (fr) * 2016-10-18 2017-11-16 Auxin Surgery Sa Dispositif, procédé et formulation pour dissection assistée de manière chimique
CA3017403A1 (en) * 2016-03-14 2017-09-21 Auxin Surgery Sa Device, method and formulation for chemically assisted dissection

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3732340A (en) * 1966-07-11 1973-05-08 Asta Werke Ag Chem Fab N',o-propylene phosphoric acid ester diamides
US4220660A (en) * 1977-12-14 1980-09-02 Asta-werke Aktiengesellschaft, Chemische Farik Process for the treatment of humans suffering from undesired urotoxic side effects caused by cytostatically active alkylating agents
US5204335A (en) * 1986-10-31 1993-04-20 Asta Pharma Aktiengesellschaft Ifosfamide lyophilisate and process for its preparation
DE3862595D1 (de) * 1987-03-06 1991-06-06 Asta Pharma Ag Verfahren zur herstellung von ifosfamid mit verbesserten eigenschaften.
DE58900183D1 (de) * 1988-03-19 1991-08-29 Asta Pharma Ag Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.
US5227373A (en) * 1991-10-23 1993-07-13 Bristol-Myers Squibb Co. Lyophilized ifosfamide compositions
DE19529057B4 (de) * 1995-08-08 2007-12-13 Baxter Healthcare S.A. Ifosfamid-Lyophilisat-Zubereitungen
DE19540132C2 (de) 1995-10-27 2003-04-03 Stada Arzneimittel Ag Ifosfamid-Lyophilisat
EP1453519A4 (en) 2001-12-13 2009-03-11 Sicor Inc AQUEOUS IFOSFAMIDE COMPOSITION
US6613927B1 (en) * 2002-02-08 2003-09-02 American Pharmaceutical Partners, Inc. Sterile lyophilized ifosfamide and associated methods
NZ538584A (en) 2002-09-05 2007-05-31 Bharat Serums & Vaccines Ltd Stable liquid composition of oxazaphosphorine, mesna and etherified beta-cyclodextrin
US7199111B2 (en) * 2002-12-02 2007-04-03 Bharat Serums & Vaccines Ltd. Aqueous ifosfamide compositions for parenteral administration and a process for their preparations

Also Published As

Publication number Publication date
JP2007507506A (ja) 2007-03-29
CY1111960T1 (el) 2015-11-04
EP1667655B1 (en) 2011-07-13
HK1091146A1 (en) 2007-01-12
WO2005032515A1 (en) 2005-04-14
ES2369776T3 (es) 2011-12-05
US8093230B2 (en) 2012-01-10
CA2540537A1 (en) 2005-04-14
SI1667655T1 (sl) 2011-10-28
ATE516014T1 (de) 2011-07-15
US20050124589A1 (en) 2005-06-09
JP2011137048A (ja) 2011-07-14
DK1667655T3 (da) 2011-10-24
EP1667655A1 (en) 2006-06-14
PT1667655E (pt) 2011-08-18
JP4886517B2 (ja) 2012-02-29

Similar Documents

Publication Publication Date Title
BG108318A (en) Carboxamide-substituted phenylurea derivatives and method for the production and use thereof as medicaments
PL364598A1 (pl) Stabilna odmiana polimorficzna flibanseryny, techniczny sposób jej wytwarzania i jej zastosowanie do otrzymywania leków
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
YU91002A (sh) Derivati acilfenil-karbamida, postupak za njihovu proizvodnju i njihova primena kao leka
DK1317419T3 (da) Cyanophenoxycarboxylsyre-forbindelser og sammensætninger til at levere aktive midler
MXPA03000510A (es) Sales estables de acido o-acetilsalicilico con aminoacidos basicos.
CY1111960T1 (el) Νεα φαρμακευτικα παρασκευασματα καθως επισης μεθοδος για την παρασκευη αυτων
GT200500257A (es) Procedimiento para producir derivados de amina opticamente activos
GEP20053650B (en) Disinfectant Solution Based on Sodium Hypochlorite, and Process for Preparing It
NO20023551D0 (no) Ibuprofen-inneholdende aktivt middel-preparat
SI1594885T1 (sl) Zdravilo za inhibiranje rasti tumorjev
UA83821C2 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли
NO20030073L (no) Medikamentleveringssystem for medikamenter som er lite vannopplöselige
MY139643A (en) Vinflunine pharmaceutical composition for parenteral administration, preparation process and use thereof.
UA86399C2 (ru) Применение 2,5 дигидроксибензолсульфоновой кислоты для изготовления лекарства, которые применяют для лечения болезней, зависимых от ангиогенеза
TW200700062A (en) Pharmaceutical compositions
PL357999A1 (pl) Nowi antagoniści LHRH, ich wytwarzanie i zastosowanie jako środka leczniczego
HRP20030762A2 (en) A stable pharmaceutical formulation comprising torsemide modofication ii
TW200745155A (en) Preparation of pharmaceutical salts of 3-O-(3',3'-dimethylsuccinyl)betulinic acid
TW200509987A (en) Use of PVP-iodine liposomes for treatment of Herpes
IL169496A0 (en) Imino acid derivatives for use as inhibitors of matrix metalloproteinases
MXPA04001851A (es) Inda-1-onas c2-disustituidas y sus derivados, metodo para su produccion y su uso como medicamentos.
MXPA05005919A (es) Composiciones de ifosfamida para la administracion parenteral, y un proceso para su preparacion.
TR200200455T2 (tr) İzotretinoin hazırlama işlemi
MXPA04002400A (es) Sales de acidos salicilicos, metodos para su preparacion y su uso como medicamentos.